Skip to main content

Veradigm Launches Enhanced Ambient Scribe Capabilities

AI-powered solution includes multilingual support, structured diagnosis code recommendations, and clinical decision insights support tools for Veradigm EHR customers

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced enhancements to the artificial intelligence (AI) enhanced Ambient Scribe solution for Veradigm EHR customers. This milestone reflects Veradigm’s commitment to delivering evolved AI solutions that improve clinical documentation, support clinical decision-making, and enhance patient care.

Since its launch last year, Veradigm Ambient Scribe has developed into a robust AI-powered solution that passively captures patient-provider conversations and generates structured clinical notes directly in the electronic health record (EHR). The latest AI-powered enhancements include:

  • Structured Diagnosis Code Recommendations: Automatically identifies and recommends ICD-10 codes that a provider can insert into the Assessment & Plan as discrete, codified diagnoses when saved to the encounter, improving clarity and precision.
  • Multilingual Documentation Support: Captures conversations in multiple languages including Spanish, Mandarin, and Arabic, and can automatically generate structured documentation in English, supporting inclusivity for diverse patient populations.
  • Clinical Decision Insights Support: Instantly displays the symptoms and care plan suggestions based on a practice’s selected care protocols and provider preferences, using an AI-driven process that generates and refines clinical insights.

“After six months of consistent use, I can confidently say that Veradigm Ambient Scribe has significantly improved my documentation quality and efficiency,” said Andrew Norris, MD, at Horizon Family Medicine.

To accelerate adoption and maximize impact, Veradigm is enhancing Ambient Scribe capabilities for Veradigm EHR customers through a staged release rollout beginning November 18, with full deployment expected within two weeks. This ensures seamless access to the latest AI capabilities without requiring added system upgrades or lengthy implementation cycles. Customers will benefit from improved efficiency and usability, driving better outcomes across clinical workflows.

“Veradigm Ambient Scribe is more than a documentation tool—it’s a clinical intelligence platform,” said Tehsin Syed, Chief Product & Technology Officer, Veradigm. “By embedding structured diagnosis code recommendations, multilingual support, and decision insights support directly into the workflow, we’re helping providers deliver more personalized, efficient, and impactful care.”

These AI-powered enhancements further Veradigm’s commitment to empowering providers with intelligent tools that reduce administrative burden, improve documentation quality, and support better patient outcomes.

For more information about Veradigm Ambient Scribe, please visit www.veradigm.com.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.

© 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.87
-1.82 (-0.78%)
AAPL  267.46
-4.95 (-1.82%)
AMD  240.52
-6.29 (-2.55%)
BAC  51.48
-1.13 (-2.15%)
GOOG  285.60
+8.62 (3.11%)
META  602.01
-7.45 (-1.22%)
MSFT  507.49
-2.69 (-0.53%)
NVDA  186.60
-3.57 (-1.88%)
ORCL  219.86
-2.99 (-1.34%)
TSLA  408.92
+4.57 (1.13%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.